ACT 1 Investigational Carotid Stenosis Trial: ACT 1 investigational trial for patients with asymtomatic carotid stenosis

Acord Trial: Treatment Study for No-Option Heart Patients with Coronary Artery Disease: Injections into the heart with a human recombinant (protein) fibroblast growth factor (FGF- investigational compound) compared to placebo. The goal is to stimulate the growth of new blood vessels around blocked coronary arteries.

Carotid Artery Stenosis Study: Carotid RX ACCULINK/RX ACCUNET postapproval trial to uncover unanticipated and rare events (CAPTURE 2)

Diet Study: Effect of a Severely Restricted Carbohydrate Diet As Compared to the TLC Diet on Triglyceride Levels in Hypertriglyceridemic Subjects

Electrophysiology (Early Repolarization): Early Repolarization Study

Fibroblast Growth Factor Study for Critical Limb Ischemia: Study of fibroblast growth factor (FGF-1) in patients who have critical limb ischemia with lesions in which revascularization is not an option.

GORE Reduce Study: GORE HELEX" Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA

Investigational mechanical circulatory support device for heart transplant candidates: Investigation of a mechanical device that provides circulatory support as a bridge to cardiac transplant in patients who are at risk of imminent death from nonreversible left ventricular failure.

Left Ventricular Assist Device Study: Study of new third generation left ventricular assist device

Longitudinal Study of Beta Blocker Utilization in Patients with Heart Failure: Longitudinal study of beta blocker utilization in patients with heart failure

Making Health Care Decisions: How people make health care decisions to treat chronic health conditions

Marvel Stem Cell Treatment Study: Study of a stem cell treatment using an investigational injection catheter in post MI congestive heart failure patients.

Miniaturized Percutaneous Circulatory Support System vs IABP (Impella): Impella investigational trial for non-emergent high-risk PCI patients.